BALTIMORE--(BUSINESS WIRE)--UNVC--
Univec, Inc. (OTCBB:UNVC) is a global, diversified
health care company devoted to development, manufacture and marketing
of pharmaceuticals and medical devices.
Univec, Inc. announced today that it has signed a license
agreement to market and manufacture Medpro Safe-Mate products. Raphael
R. Langford, Executive Vice President and COO of Univec stated,
"Univec is pleased to announce this alliance with Medpro, Inc., a
privately held company. Under the terms of the agreement, Medpro and
Univec will integrate their technology to deliver safe needle products
to the dental market. Univec will manufacture and distribute compliant
needle stick risk management technology to dental providers. We are
aggressively focusing on alliances, growth, and additional support for
our in-line products and maximizing upcoming launches."

About Univec

Founded in 1992, Univec is considered one of the leading
innovators in the design and production of the Sliding-Sheath Safety
Syringe. Univec is an integrated licensing, manufacturing and
marketing company dedicated to providing safer health products to
patients and caregivers worldwide. Univec meets one or more
requirements under the FDA, ISO 9002 and GMP in facilities in
Maryland, Portugal, Belgium, China, and South Korea.
PPSI (PHYSICIAN AND PHARMACEUTICAL SERVICES, INC.) a division of
Univec, promotes and pays for pharmaceutical products though its
network of pharmacies. PPSI eliminates the need for the pharmaceutical
companies to distribute actual drug samples to physicians reducing
potential liability for the physician while maintaining clinical
oversight and drug interaction checks for the patient. Univec also
assists pharmaceutical companies in marketing and providing drug
samples to physicians.
Univec's strategic alliances include Pharmacy Services, Inc., a
prescription fulfillment center, and Health Resources, Inc., a
pharmacy benefit management company.
Univec's mission is to return value to shareholders through the
development, license, manufacture, and sale of safer medical products.
Univec also recognizes and values the immense positive social and
economic benefit that the Company's products continue to make by
helping prevent the spread of disease. The Company distributes its
products to over 80 countries worldwide.

Forward Looking Statements

This document contains forward-looking statements based on current
expectations that could be affected by the risks and uncertainties
involved in Univec's business. These risks and uncertainties include,
but are not limited to, the risks described from time to time in
Univec's reports to the Securities and Exchange Commission, which
include Univec's Annual Report on Form 10-KSB. Subsequent written or
oral statements attributable to Univec or persons acting on its behalf
are expressly qualified in their entirety by the cautionary statements
in this document and those in Univec's reports filed with the
Securities and Exchange Commission.

KEYWORD: MARYLAND
INDUSTRY KEYWORD: PHARMACEUTICAL MEDICAL DEVICES MEDICAL MARKETING AGREEMENTS
SOURCE: Univec, Inc.

CONTACT INFORMATION:
Univec, Inc.
Raphael Langford, 410-347-9959